To see all exchange delays and terms of use please see Barchart’s disclaimer. Pfizer Inc. was founded in 1849 by Charles Pfizer Sr. and his cousin Charles Earhart. The two were German immigrants and chemists that set up shops outside New York City to make medicinal compounds. The first major success was an antiparasitic called santonin, and the commercialization of citric acid-making technologies quickly followed that up. Their success with citric acid led to the company’s expansion and other major discoveries. Select to analyze similar companies using key performance metrics; select up to 4 stocks.
MarketBeat All Access Features
Whether you’re planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions. Pfizer Inc was incorporated on June 2nd, 1942 in Delaware, and another period of expansion began. The postwar drop in demand for penicillin led to the discovery of newer, more marketable antibiotics and cemented the company’s role in modern medicine. By the time he 80s rolled around, the company was trading on the New York Stock Exchange and on the path to developing today’s blockbuster lineup. Discover which analysts rank highest on predicting the price target of PFE. Discover which analysts rank highest for PFE overall weighted by direction, price target, and price movement.
- You’ll need access to an options trading platform, or a broker who will allow you to ‘go short’ a share of stock by lending you the shares to sell.
- Discover which analysts rank highest on predicting the directional movement of PFE.
- Despite these issues, Meekins suggests that the recent sell-off in pharmaceutical and GLP-1 stocks may be an overreaction.
- Pfizer Inc. is a research-based global biopharmaceutical company, which engages in the discovery, development, manufacture, marketing, sales and distribution of biopharmaceutical products worldwide.
Wall Street’s Most Accurate Analysts Weigh In On 3 Health Care Stocks With Over 5% Dividend Yields
Some of these companies are using artificial intelligence in unbelievable ways. The Oracle of Omaha has concentrated Berkshire’s investment portfolio in his best ideas. You can click the graphic below for the historical numbers, but it shows that as of September 2024 Pfizer had US$67.9b of debt, an increase on US$64.1b, over one year. However, because it has a cash reserve 1 gbp to usd or 1 british pound to us dollar of US$9.95b, its net debt is less, at about US$58.0b. Shares in some of America’s largest drug manufacturers tumbled yesterday after President-elect Donald Trump announced Robert F. Kennedy Jr. as his pick for secretary of the Department of Health and Hu…
We can see from the most recent balance sheet that Pfizer had liabilities of US$43.2b falling due within a year, and liabilities of US$83.7b due beyond that. Offsetting these obligations, it had cash of US$9.95b as well as receivables valued at US$17.7b due within 12 months. So its liabilities outweigh the sum of its cash and (near-term) receivables by US$99.3b. Analysts warn that any major shifts in vaccine policy or regulatory frameworks could have far-reaching consequences for the pharmaceutical sector, with Pfizer among the most exposed.
Dividend Stocks That Are Screaming Buys in November
By replacing dilution, though, debt can be an extremely good tool for businesses that need capital to invest in growth at high rates of return. The first step when considering a company’s debt levels is to consider its cash and debt together. Pfizer’s stock appears undervalued with a high dividend yield of 6.8%, making it a potential long-term investment despite low growth expectations.
Pfizer’s EBIT growth rate was a real negative on this analysis, although the other factors we considered cast it in a significantly better light. But on the bright side, its ability to to convert EBIT to free cash flow isn’t too shabby at all. When we consider all the factors discussed, it seems to us that Pfizer is taking some risks with its use brokerage house financial definition of brokerage house of debt. While that debt can boost returns, we think the company has enough leverage now.
It is the 2nd largest drugmaker globally by revenue and is japan’s rakuten securities to offer trailing orders to fx traders ranked 64th on the Fortune 500 list. The company’s avenues of research include Immunology, Oncology, Cardiology, Endocrinology and Neurology. Alternatively, email editorial-team (at) simplywallst.com.This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data.
Pfizer scored higher than 100% of companies evaluated by MarketBeat, and ranked 1st out of 953 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Please bear with us as we address this and restore your personalized lists.